vaccine

The European Parliament has supported an amendment calling for Europe to support the temporary suspension of intellectual property rules for Covid-19 vaccines, tests, and treatments. In reaction to this vote, Evelien van Roemburg, head of Oxfam EU office, said: "This vote sends a strong signal that Europeans stand shoulder to shoulder with the people of the world in the fight against the pandemic."

Less than half (49 per cent) of the 2.1 billion COVID vaccine donations promised to poorer countries by G7 countries have been delivered, according to new figures published today by Oxfam and the People’s Vaccine Alliance.  

The human and economic cost of COVID-19 has been staggering, in terms of lives lost, human suffering, and economic damage. As we mark two years since the official pandemic was declared, we still have a chance to gain the upper hand on the virus, but only if everyone, everywhere has access to vaccines and treatments.

As we continue to fight against the Covid-19 pandemic, it is vital that no one is excluded from vaccine coverage. This briefing note addresses some of the challenges faced by displaced people – including refugees, asylum seekers, IDPs, stateless people, and others in displacement contexts – in accessing Covid-19 vaccinations.

In response to the announcement that AstraZeneca is to move away from the non-profit model for COVID vaccines, Anna Marriott, Oxfam’s Health Policy Manager and spokesperson for the People’s Vaccine Alliance, said: “AstraZeneca is breaking its repeated and celebrated public promises of a non-profit vaccine for all countries for the duration of this pandemic and to never to make a profit in any low- and middle-income country from this publicly funded vaccine."
 

An international coalition of human rights law groups, public health experts, and civil society organisations is taking legal action against the US, UK, Germany, Norway, and Switzerland, on the grounds that these countries are in violation of international human rights law by failing to intervene on what has been an inequitable and racially discriminatory rollout of the vaccine and other COVID healthcare technologies. 

Responding to an International Labour Organisation’s report, ILO Monitor: COVID-19 and the world of work, campaigners have called global vaccine inequality “a collective act of social and economic self-harm”.

Vaccine equity campaigners have called news that Covid-19 vaccine manufacturer BioNTech will start building a vaccine production facility in Rwanda next year “far too little, far too late”. 

The People’s Vaccine Alliance has also said that Moderna’s new commitment to produce 110 million doses for the African Union as “barely worth the paper it is written on” after the company failed to deliver promised vaccines to COVAX, calling on the US government to step in and mandate the company to commit to technology transfer.

Developing countries have been hit with an endless tide of inadequate gestures and broken promises from rich countries and pharmaceutical companies, who are failing to deliver billions of doses they promised while blocking the real solutions to vaccine inequality, according to a new report published today by the People’s Vaccine Alliance. 

As the UN General Assembly kicks off again this year, Oxfam’s experts and partners are available to speak to their work focused on the People’s Vaccine for COVID-19, the climate crisis - including climate finance, and a number of pressing humanitarian crises.